Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel Luteijn

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos One|December 2, 2021
A model framework for projecting the prevalence and impact of Long-COVID in the UKChris Martin, Michiel Luteijn, William Letton, et al.
BMC Medical Informatics and Decision Making|April 28, 2021
Construction of a demand and capacity model for intensive care and hospital ward beds, and mortality from COVID-19Christopher Martin, Stuart McDonald, Steve Bale, et al.
European Journal of Epidemiology|March 7, 2016
Cost-benefit analysis of the polypill in the primary prevention of myocardial infarction and strokeNicholas J Wald, Johannes Michiel Luteijn, Joan K Morris, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2010
Costs and consequences of additional chest x-ray in a tuberculosis prevention program in BotswanaTaraz Samandari, David Bishai, Michiel Luteijn, et al.
Plos One|April 13, 2011
Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureusGijs Hubben, Martin Bootsma, Michiel Luteijn, et al.
Drug Safety|November 5, 2011
Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agenciesIneke Crijns, Sabine Straus, Michiel Luteijn, et al.
Epidemiology (Cambridge, Mass.)|September 2, 2015
The Association of H1N1 Pandemic Influenza with Congenital Anomaly Prevalence in Europe: An Ecological Time Series StudyJohannes Michiel Luteijn, Marie-Claude Addor, Larraitz Arriola, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|March 19, 2014
Seasonality of congenital anomalies in EuropeJohannes Michiel Luteijn, Helen Dolk, Marie-Claude Addor, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|December 2, 2021
A model framework for projecting the prevalence and impact of Long-COVID in the UKChris Martin, Michiel Luteijn, William Letton, et al.
BMC Medical Informatics and Decision Making|April 28, 2021
Construction of a demand and capacity model for intensive care and hospital ward beds, and mortality from COVID-19Christopher Martin, Stuart McDonald, Steve Bale, et al.
European Journal of Epidemiology|March 7, 2016
Cost-benefit analysis of the polypill in the primary prevention of myocardial infarction and strokeNicholas J Wald, Johannes Michiel Luteijn, Joan K Morris, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2010
Costs and consequences of additional chest x-ray in a tuberculosis prevention program in BotswanaTaraz Samandari, David Bishai, Michiel Luteijn, et al.
Plos One|April 13, 2011
Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureusGijs Hubben, Martin Bootsma, Michiel Luteijn, et al.
Drug Safety|November 5, 2011
Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agenciesIneke Crijns, Sabine Straus, Michiel Luteijn, et al.
Epidemiology (Cambridge, Mass.)|September 2, 2015
The Association of H1N1 Pandemic Influenza with Congenital Anomaly Prevalence in Europe: An Ecological Time Series StudyJohannes Michiel Luteijn, Marie-Claude Addor, Larraitz Arriola, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|March 19, 2014
Seasonality of congenital anomalies in EuropeJohannes Michiel Luteijn, Helen Dolk, Marie-Claude Addor, et al.
Pageof 1